UPDATED ON FEB 15, 2021 02:33 PM IST
While there are currently no effective treatments for metastatic papillary kidney cancer, or metastatic pRCC, experts have found that Cabozantinib drug is most effective in treating patients suffering from this rare subtype of kidney cancer
New Delhi | By HT Correspondent
PUBLISHED ON NOV 02, 2019 11:00 PM IST
Even though advancement in cancer cure in the past few decades has made it possible to treat nearly 80% of all childhood cancers globally, the percentage is lower in India mainly because there is still lack of sufficient awareness.